BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15787326)

  • 1. Clinical efficacy of distigmine bromide in the treatment of patients with underactive detrusor.
    Bougas DA; Mitsogiannis IC; Mitropoulos DN; Kollaitis GC; Serafetinides EN; Giannopoulos AM
    Int Urol Nephrol; 2004; 36(4):507-12. PubMed ID: 15787326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Symptomatic and urodynamic improvement by oral distigmine bromide in poor voiders after transurethral resection of the prostate.
    Tanaka Y; Masumori N; Itoh N; Furuya S; Nishizawa O; Tsukamoto T
    Urology; 2001 Feb; 57(2):270-4. PubMed ID: 11182335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distigmine bromide and post-prostatectomy voiding.
    Shah PJ; Abrams PH; Choa RG; Ashken MH; Gaches CG; Green NA; Wiles A
    Br J Urol; 1983 Apr; 55(2):229-32. PubMed ID: 6132645
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of distigmine at 5 mg daily in patients with detrusor underactivity].
    Sugaya K; Kadekawa K; Onaga T; Ashitomi K; Mukouyama H; Nakasone K; Shimabukuro H; Shimabukuro S; Matayoshi Y; Hokama S; Touyama Y; Nishijima S
    Nihon Hinyokika Gakkai Zasshi; 2014 Jan; 105(1):10-6. PubMed ID: 24605581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical effects of distigmine bromide (Ubretid), a cholinesterase inhibitor, on micturition disturbance by benign prostatic hypertrophy--comparative study of distigmine bromide and the combination of distigmine bromide and adrenergic blocker].
    Katsumi T; Murayama K
    Hinyokika Kiyo; 1992 Sep; 38(9):1089-92. PubMed ID: 1384297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of a cholinergic drug and an alpha-blocker is more effective than monotherapy for the treatment of voiding difficulty in patients with underactive detrusor.
    Yamanishi T; Yasuda K; Kamai T; Tsujii T; Sakakibara R; Uchiyama T; Yoshida K
    Int J Urol; 2004 Feb; 11(2):88-96. PubMed ID: 14706012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of acotiamide hydrochloride hydrate in patients with detrusor underactivity.
    Sugimoto K; Akiyama T; Shimizu N; Matsumura N; Hayashi T; Nishioka T; Uemura H
    Res Rep Urol; 2015; 7():81-3. PubMed ID: 26056686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Silodosin, an α1A-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats.
    Tatemichi S; Tsuchioka K; Yonekubo S; Maruyama K; Kobayashi M
    Pharmacology; 2015; 95(5-6):285-92. PubMed ID: 26023044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Conservative treatment of hypocontractile bladder emptying disturbances (author's transl)].
    Riccabona M
    Dtsch Med Wochenschr; 1981 Nov; 106(47):1579-82. PubMed ID: 6118249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distigmine bromide and stress incontinence in women.
    Shah PJ; Abrams PH
    Prog Clin Biol Res; 1981; 78():329-34. PubMed ID: 6121333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder.
    Izumi K; Maolake A; Maeda Y; Shigehara K; Namiki M
    Minerva Urol Nefrol; 2014 Dec; 66(4):241-7. PubMed ID: 25531193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury.
    Sugaya K; Nishijima S; Kadekawa K; Ashitomi K; Yamamoto H
    Int J Urol; 2012 May; 19(5):480-3. PubMed ID: 22221137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Demonstration of muscarinic and nicotinic receptor binding activities of distigmine to treat detrusor underactivity.
    Harada T; Fushimi K; Kato A; Ito Y; Nishijima S; Sugaya K; Yamada S
    Biol Pharm Bull; 2010; 33(4):653-8. PubMed ID: 20410601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder].
    Tada M; Fujita N; Umeda M; Koike H; Nagai H
    No To Shinkei; 2004 May; 56(5):415-9. PubMed ID: 15279199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity.
    Obara K; Ogawa T; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(7):1092-1100. PubMed ID: 28674252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distigmine bromide (Ubretid) for the prevention of urinary retention after vaginal hysterectomy.
    Walsh J; Bonnar J
    J Obstet Gynaecol Br Commonw; 1972 Apr; 79(4):377-8. PubMed ID: 5025144
    [No Abstract]   [Full Text] [Related]  

  • 17. [Acute poisoning due to distigmine bromide].
    Onodera M
    Chudoku Kenkyu; 2008 Apr; 21(2):161-7. PubMed ID: 18516941
    [No Abstract]   [Full Text] [Related]  

  • 18. Different evolution of voiding function in underactive bladders with and without detrusor overactivity.
    Cucchi A; Quaglini S; Rovereto B
    J Urol; 2010 Jan; 183(1):229-33. PubMed ID: 19913829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
    Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
    J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamic evidence of effectiveness of botulinum A toxin injection in treatment of detrusor overactivity refractory to anticholinergic agents.
    Kuo HC
    Urology; 2004 May; 63(5):868-72. PubMed ID: 15134967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.